Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(50.0%)
Phase 2
2(50.0%)
4Total
N/A(2)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05443295Not ApplicableCompleted

Improvement of Fatigue in Unstable Shoulder Through a Therapeutic Exercise Program in Physiotherapy

Role: collaborator

NCT04891445Not ApplicableCompleted

Hepatitis C in Severe Mental Disorders: Nursing Programme

Role: collaborator

NCT04400019Phase 2Unknown

Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)

Role: collaborator

NCT03075735Completed

Prospective Multicentre Cohort Study PROREPAIR-B (mCRPC)

Role: collaborator

NCT02928432Phase 2Completed

SWITCH: Study of the Prednisone to Dexamethasone Change in mCRPC Patients Treated With Abiraterone

Role: collaborator

All 5 trials loaded